OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Showing 7 citing articles:
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients
Mila B. Ortigoza, Hyunah Yoon, Keith Goldfeld, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 115-115
Open Access | Times Cited: 82
Mila B. Ortigoza, Hyunah Yoon, Keith Goldfeld, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 115-115
Open Access | Times Cited: 82
Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Experience with COVID ‐19 convalescent plasma provides vital guidance to future pandemics
Jan Hartmann, Evan M. Bloch, Thierry Burnouf
Transfusion (2022) Vol. 62, Iss. 3, pp. 681-684
Open Access | Times Cited: 8
Jan Hartmann, Evan M. Bloch, Thierry Burnouf
Transfusion (2022) Vol. 62, Iss. 3, pp. 681-684
Open Access | Times Cited: 8
WHO covid-19 drugs guideline: reconsider using convalescent plasma
Nigel Paneth, Arturo Casadevall, Liise-anne Pirofski, et al.
BMJ (2022), pp. o295-o295
Closed Access | Times Cited: 7
Nigel Paneth, Arturo Casadevall, Liise-anne Pirofski, et al.
BMJ (2022), pp. o295-o295
Closed Access | Times Cited: 7
Convalescent plasma for COVID-19. TSUNAMI is not the final word
Massimo Franchini, Daniele Focosi, Arturo Casadevall, et al.
European Journal of Internal Medicine (2022) Vol. 97, pp. 116-118
Open Access | Times Cited: 5
Massimo Franchini, Daniele Focosi, Arturo Casadevall, et al.
European Journal of Internal Medicine (2022) Vol. 97, pp. 116-118
Open Access | Times Cited: 5
Lack of a prompt normalization of immunological parameters is associated with long-term care and poor prognosis in COVID-19 affected patients receiving convalescent plasma: a single center experience
Daniele Moratto, Elda Mimiola, Federico Serana, et al.
Diagnosis (2022) Vol. 10, Iss. 2, pp. 193-199
Open Access | Times Cited: 2
Daniele Moratto, Elda Mimiola, Federico Serana, et al.
Diagnosis (2022) Vol. 10, Iss. 2, pp. 193-199
Open Access | Times Cited: 2
Experiences in the use of multiple doses of convalescent plasma in critically ill patients with COVID-19
Ricardo Aguilar, Sandra López‐Vergès, Anarellys Quintana, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Ricardo Aguilar, Sandra López‐Vergès, Anarellys Quintana, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
